Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin plus vitamin E for breast pain and fibroadenoma size
IRCT20191104045328N21Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- May 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of metformin and vitamin e in adenofibroma, sponsored by Arak University of Medical Sciences. Primary endpoints: Improvement in breast pain and Change in fibroadenoma size. Started May 2024; status: completed.
02
Drugs
metforminvitamin e
03
Conditions
adenofibroma
Beyond the preview
Go deeper on IRCT20191104045328N21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191104045328N21.